Delivery Order SPE2DB20D3101-SPE2DB23FRPU4
Award Date
6/20/23
Potential Completion Date
6/21/23
Potential Value
$2.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Ondansetron HCL 8 mg tablets to the Defense Logistics Agency (DLA). The $9,232.09 delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a firm fixed price pricing type and no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
This federal contract award is for the delivery of Ondansetron HCL 8 mg tablets to the Defense Logistics Agency (DLA). The $6,861.75 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle...
This federal contract award is for the delivery of Ondansetron ODT 4 mg tablets to the Defense Logistics Agency (DLA). The $2,500.32 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of May 5, 2023 and was not set aside for any specific business type. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for the delivery of Ondansetron HCl 8 mg tablets to the Defense Logistics Agency (DLA). The contract, valued at $15,314.72, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of February 6, 2024, and was awarded on February 5, 2024. This appears to be a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which is...
This federal contract award, issued by the Defense Logistics Agency (DLA), is a Delivery Order valued at $2,154.60 for the supply of Ondansetron ODT 8 mg tablets. The prime contractor is AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of March 11, 2025 and is a Firm Fixed Price agreement. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the...
This federal contract award is for the delivery of Ondansetron ODT 8 mg tablets to the Defense Logistics Agency (DLA). The $13,863.34 firm fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a period of performance through December 11, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award is for the delivery of Ondansetron ODT 8 mg tablets to the Defense Logistics Agency (DLA). The $2,681.08 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor that serves as a critical supplier to various government agencies, including the Department of Defense and Department of Veterans Affairs healthcare systems. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a...
This federal contract award is for the delivery of 4563816196 Ondansetron ODT 4 mg tablets in quantities of 30 to the Defense Logistics Agency (DLA). The $16,342.90 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The ultimate completion date for this order is March 1, 2024. AmerisourceBergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award is for the delivery of Ondansetron ODT 8 mg tablets to the Defense Logistics Agency (DLA). The contract, valued at $9,708.47, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price. The contract is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC,...
This federal contract award is for the supply of Ondansetron HCL 4 mg tablets to the Defense Logistics Agency (DLA). The $4,735.89 delivery order was awarded to Amerisourcebergen Drug Corp, a pharmaceutical distribution company owned by the parent company Cencora, Inc. The contract has an ultimate completion date of May 16, 2023 and is a firm fixed price delivery order, with no set-aside designation. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...